StockWatch
·
Medical/Nursing Services
DealsJun 5, 2026, 04:23 PM

VSee Health Sells Subsidiary VSee Lab to Co-CEO Milton Chen; CEO Transition

AI Summary

VSee Health, Inc. has entered into a Stock Purchase Agreement to sell its wholly-owned subsidiary, VSee Lab, Inc., to its co-CEO and Chairman, Milton Chen. In connection with the sale, Mr. Chen resigned from his positions at VSee Health, and Dr. Imoigele Aisiku was appointed as the sole CEO and Chairman. The transaction involved the exchange of VSee Lab equity for Mr. Chen's shares in VSee Health. Pro forma financial statements show a reduction in net loss for both the first quarter of 2026 and the full year 2025 following the divestment.

Key Highlights

  • VSee Health sells its wholly-owned subsidiary, VSee Lab, to co-CEO and Chairman Milton Chen.
  • Milton Chen resigns as co-CEO and Chairman of VSee Health, effective upon closing.
  • Dr. Imoigele Aisiku appointed sole CEO and Chairman of VSee Health.
  • VSee Health's pro forma net loss for Q1 2026 was $1.26M, compared to $2.60M historically.
  • VSee Health's pro forma net loss for FY 2025 was $9.97M, compared to $14.71M historically.